Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Ziegler

Showing results (31-40 of 174) with videos related to

Pageof 18
Sort By:
Cell Death & Disease|March 27, 2026
RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibitionSamuel E Ross, Holly Holliday, Eyden Wang, et al.
Nature Reviews. Cancer|April 11, 2018
Too many targets, not enough patients: rethinking neuroblastoma clinical trialsJamie I Fletcher, David S Ziegler, Toby N Trahair, et al.
JMIR Research Protocols|May 6, 2018
The Development of Delta: Using Agile to Develop a Decision Aid for Pediatric Oncology Clinical Trial EnrollmentEden G Robertson, Claire E Wakefield, Richard J Cohn, et al.
Cancer Medicine|June 20, 2024
The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancerEden G Robertson, Kate Hetherington, Rebecca Daly, et al.
Molecular Cancer Therapeutics|September 8, 2023
Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine GliomasAnahid Ehteda, Aaminah Khan, Gayathiri Rajakumar, et al.
Frontiers in Oncology|November 28, 2012
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastomaLaura D Gamble, Michael D Hogarty, Xueyuan Liu, et al.
The Oncologist|February 28, 2019
Predictors of Success of Phase II Pediatric Oncology Clinical TrialsLaura Franshaw, Maria Tsoli, Jennifer Byrne, et al.
Journal of Pediatric Hematology/Oncology|May 26, 2018
Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse TreatmentAditi Vedi, Richard Mitchell, Sunita Shanmuganathan, et al.
Neuro-Oncology Advances|November 16, 2020
A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettesDerek Hanson, Lindsey M Hoffman, Sumanth Nagabushan, et al.
The Journal of Clinical Investigation|June 16, 2020
Immune profiling of pediatric solid tumorsRachael L Terry, Deborah Meyran, David S Ziegler, et al.
Pageof 18

Showing results (31-40 of 174) with videos related to

Sort By:
Pageof 18
Cell Death & Disease|March 27, 2026
RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibitionSamuel E Ross, Holly Holliday, Eyden Wang, et al.
Nature Reviews. Cancer|April 11, 2018
Too many targets, not enough patients: rethinking neuroblastoma clinical trialsJamie I Fletcher, David S Ziegler, Toby N Trahair, et al.
JMIR Research Protocols|May 6, 2018
The Development of Delta: Using Agile to Develop a Decision Aid for Pediatric Oncology Clinical Trial EnrollmentEden G Robertson, Claire E Wakefield, Richard J Cohn, et al.
Cancer Medicine|June 20, 2024
The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancerEden G Robertson, Kate Hetherington, Rebecca Daly, et al.
Molecular Cancer Therapeutics|September 8, 2023
Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine GliomasAnahid Ehteda, Aaminah Khan, Gayathiri Rajakumar, et al.
Frontiers in Oncology|November 28, 2012
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastomaLaura D Gamble, Michael D Hogarty, Xueyuan Liu, et al.
The Oncologist|February 28, 2019
Predictors of Success of Phase II Pediatric Oncology Clinical TrialsLaura Franshaw, Maria Tsoli, Jennifer Byrne, et al.
Journal of Pediatric Hematology/Oncology|May 26, 2018
Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse TreatmentAditi Vedi, Richard Mitchell, Sunita Shanmuganathan, et al.
Neuro-Oncology Advances|November 16, 2020
A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettesDerek Hanson, Lindsey M Hoffman, Sumanth Nagabushan, et al.
The Journal of Clinical Investigation|June 16, 2020
Immune profiling of pediatric solid tumorsRachael L Terry, Deborah Meyran, David S Ziegler, et al.
Pageof 18